Fiduciary Trust Co Increases Stock Position in UnitedHealth Group Incorporated (NYSE:UNH)

Fiduciary Trust Co increased its stake in shares of UnitedHealth Group Incorporated (NYSE:UNHFree Report) by 0.8% in the fourth quarter, HoldingsChannel.com reports. The firm owned 69,869 shares of the healthcare conglomerate’s stock after buying an additional 545 shares during the period. Fiduciary Trust Co’s holdings in UnitedHealth Group were worth $36,784,000 at the end of the most recent quarter.

A number of other large investors also recently added to or reduced their stakes in the company. Wellington Management Group LLP increased its stake in UnitedHealth Group by 2.1% during the 3rd quarter. Wellington Management Group LLP now owns 25,220,234 shares of the healthcare conglomerate’s stock worth $12,715,790,000 after buying an additional 527,526 shares during the period. Norges Bank purchased a new position in UnitedHealth Group in the fourth quarter valued at $5,802,231,000. Northern Trust Corp increased its holdings in UnitedHealth Group by 3.6% during the 3rd quarter. Northern Trust Corp now owns 9,787,768 shares of the healthcare conglomerate’s stock worth $4,934,895,000 after purchasing an additional 341,749 shares during the period. Charles Schwab Investment Management Inc. boosted its stake in shares of UnitedHealth Group by 2.4% in the 4th quarter. Charles Schwab Investment Management Inc. now owns 5,984,853 shares of the healthcare conglomerate’s stock valued at $3,143,004,000 after buying an additional 141,646 shares during the period. Finally, Sanders Capital LLC raised its holdings in UnitedHealth Group by 6.5% in the third quarter. Sanders Capital LLC now owns 5,757,410 shares of the healthcare conglomerate’s stock valued at $2,902,829,000 after acquiring an additional 352,710 shares in the last quarter. 87.86% of the stock is currently owned by institutional investors and hedge funds.

UnitedHealth Group Stock Performance

Shares of NYSE UNH traded down $1.53 during mid-day trading on Thursday, hitting $483.19. 3,513,916 shares of the company were exchanged, compared to its average volume of 4,179,823. The company has a quick ratio of 0.85, a current ratio of 0.85 and a debt-to-equity ratio of 0.69. The firm has a market cap of $444.72 billion, a price-to-earnings ratio of 29.52, a price-to-earnings-growth ratio of 1.46 and a beta of 0.55. The stock has a 50 day simple moving average of $489.67 and a 200-day simple moving average of $509.89. UnitedHealth Group Incorporated has a 1-year low of $436.38 and a 1-year high of $554.70.

UnitedHealth Group (NYSE:UNHGet Free Report) last announced its quarterly earnings data on Tuesday, April 16th. The healthcare conglomerate reported $6.91 EPS for the quarter, beating analysts’ consensus estimates of $6.63 by $0.28. The firm had revenue of $99.80 billion during the quarter, compared to the consensus estimate of $99.23 billion. UnitedHealth Group had a net margin of 4.05% and a return on equity of 26.50%. The firm’s revenue was up 8.6% compared to the same quarter last year. During the same quarter last year, the firm earned $6.26 earnings per share. On average, sell-side analysts forecast that UnitedHealth Group Incorporated will post 27.6 EPS for the current fiscal year.

Analyst Ratings Changes

A number of equities research analysts have commented on the stock. Deutsche Bank Aktiengesellschaft increased their price objective on shares of UnitedHealth Group from $545.00 to $562.00 and gave the company a “buy” rating in a research report on Friday, April 19th. Robert W. Baird assumed coverage on UnitedHealth Group in a report on Thursday. They set an “outperform” rating and a $597.00 price target for the company. Cantor Fitzgerald reissued an “overweight” rating and set a $591.00 target price on shares of UnitedHealth Group in a research report on Wednesday, April 10th. Stephens reissued an “overweight” rating and set a $605.00 price objective on shares of UnitedHealth Group in a report on Thursday, February 8th. Finally, Piper Sandler increased their target price on shares of UnitedHealth Group from $566.00 to $571.00 and gave the company an “overweight” rating in a research report on Wednesday, April 17th. Three investment analysts have rated the stock with a hold rating and seventeen have issued a buy rating to the company’s stock. According to data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $572.75.

View Our Latest Analysis on UNH

Insiders Place Their Bets

In other UnitedHealth Group news, EVP Erin Mcsweeney sold 1,236 shares of the company’s stock in a transaction dated Friday, March 8th. The shares were sold at an average price of $483.48, for a total transaction of $597,581.28. Following the transaction, the executive vice president now directly owns 9,364 shares in the company, valued at $4,527,306.72. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. 0.33% of the stock is currently owned by company insiders.

UnitedHealth Group Profile

(Free Report)

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

Recommended Stories

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNHFree Report).

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.